SCHEMBL6966376

SCHEMBL6966376

N#Cc1ccc(N2CC(CN3CCC(c4c[nH]c5ccccc45)CC3)OC2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 1/20 0.47
CYP2D6 P10635 1/20 0.46
GRM2 Q14416 1/20 0.45
ADRA1D P25100 4/20 0.45
SLC6A4 P31645 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6966803 0.91 SLC6A4 (0.48) GRM2SLC6A4
SCHEMBL6967736 0.91 SLC6A4 (0.48) GRM2SLC6A4
SCHEMBL6964919 0.91 SLC6A4 (0.48) GRM2SLC6A4
SCHEMBL5527597 0.90 CYP2D6 (0.52) CYP2D6ADRA1DSLC6A4
SCHEMBL6962326 0.90 SLC6A4 (0.47) SLC6A4
SCHEMBL6962409 0.88 CYP2D6 (0.48) CCR2CYP2D6ADRA1DSLC6A4
SCHEMBL6961404 0.88 CYP2D6 (0.48) CYP2D6ADRA1DSLC6A4
SCHEMBL6968341 0.88 OPRM1 (0.52) GRM2SLC6A4
SCHEMBL6965715 0.88 OPRM1 (0.52) GRM2SLC6A4
SCHEMBL6956398 0.88 DRD2 (0.49) GRM2ADRA1DSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0964863-B1 OXAZOLIDINES AS 5-HT2A-ANTAGONISTS MERCK PATENT GMBH (DE) 2003-05-21 EP disclosed
US-6462056-B1 SUCH AS 3-(4-CHLOROPHENYL)-5-(4-(3-INDOLYL)-1-PIPERIDINYL-METHYL)OXAZOLIDIN-2-ONE; 5-HT2A ANTAGONISTS WITH 5-HT REUPTAKE INHIBITING, ANTIDEPRESSANT OR ANXIOLYTIC EFFECT MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2002-10-08 US disclosed
EP-0964863-A1 OXAZOLIDINES AS 5-HT2A-ANTAGONISTS MERCK PATENT GmbH (DE) 1999-12-22 EP disclosed
WO-1998038189-A1 OXAZOLIDINES AS 5-HT2A-ANTAGONISTS MERCK PATENT GMBH (DE) 1998-09-03 WO disclosed